Ionis Pharmaceuticals Inc. held its virtual Annual Meeting of Stockholders on June 5, 2025. Stockholders considered several proposals during the meeting. The election of directors was approved by the stockholders. An amendment to the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan, which increases the aggregate number of shares authorized for issuance by 4,000,000 shares, was also approved. Additionally, the selection of Ernst & Young LLP as independent auditors for the 2025 fiscal year was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ionis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-022001), on June 10, 2025, and is solely responsible for the information contained therein.
精彩评论